Dr Anthony J Foti

Dr Anthony J Foti Eye Care Specialist providing a comprehensive eye exam

Comprehensive eye exams with cataract and glaucoma evaluations

Sports vision and vision training

Contact len services: Disposable, daily wear, color, astigmatic, and custom fits

Fashionable eyewear : Come see our large selection of fashionable eyewear


Sports and safety glasses, as well as a large selection of sunglasses

Facilities and Equipment
Our facility utulizes the most sophisticated

equipment like our Welsch Allen Auto refractor, Nikon Fundus camera or Oculus Visual Field Analyzer. Our Modern eyeglass dispensery carries over a thousand frames from many fashion designers and brands like Nike, Guess and Escarta.

Spring into new styles! Make an appointment and mention Spring2025 and get 20% off on Eye Ware!
04/22/2025

Spring into new styles! Make an appointment and mention Spring2025 and get 20% off on Eye Ware!

01/21/2025

The staying power of bifocal contact lens benefits in young kids
After treatment, nearsightedness progresses at age-expected rate
photo:Emily Caldwell
Follow me on X (opens in new window) Add me on LinkedIn (opens in new window)
Emily Caldwell
Ohio State News
caldwell.151@osu.edu
Young nearsighted kids who wear bifocal contact lenses that slow uncoordinated eye growth do not lose the benefits of the treatment once they stop wearing the lenses, new research shows.

The study is a follow-up to a clinical trial published in 2020 showing that soft multifocal contact lenses with a heavy dose of added reading power dramatically slowed further progression of myopia in kids as young as 7 years old. Researchers wondered if discontinuing that treatment might cause a rebound of faster-than-normal eye growth that wipes out the benefit.

Jeffrey Walline
Jeffrey Walline
In the new trial, nearsighted kids wore high-add bifocal lenses for two years followed by one year with single-vision contact lenses. Results showed no evidence that the treatment effect declined, and myopia progression then continued at age-expected rates.

“We want doctors to understand that you don’t lose the benefits that you gain with this treatment,” said senior author Jeffrey Walline, professor of optometry at The Ohio State University and chair of the project, known as the BLINK (Bifocal Lenses in Nearsighted Kids) Study.

“But more importantly, what we want to do with this research is give patients healthier eyes at a lower cost with more options. And then in adulthood, we want them to be able to function fully and with clear vision.”

The new follow-up study, known as BLINK2, is published today (Jan. 16, 2025) in JAMA Ophthalmology. Both trials were conducted at Ohio State and the University of Houston.

In nearsightedness, or myopia, the eye grows and is stretched into an elongated shape. This abnormality increases the risk for cataracts, detached retina, glaucoma and myopic macular degeneration, all of which can lead to loss of vision, even when wearing glasses or contact lenses.

Myopia is also common, affecting at least one-third of adults in the United States, and is becoming more prevalent – because, the scientific community believes, children are spending less time outdoors now than in the past. Nearsightedness tends to begin between the ages of 8 and 10 and progresses up to about age 18, when the eye might continue to grow but not become more myopic in most people.

Multifocal contact lenses for nearsighted patients correct for clear distance vision and include focal power that allows middle-aged eyes to read near work clearly.

In the original study, 294 nearsighted children aged 7-11 years were randomized into one of three groups of contact-lens wearers. Those who wore the lenses with the highest added power, 2.50 diopters, had shorter eyes and slower rates of myopia progression than the kids in the other two groups after three years.

Of the original participants, 248 continued in BLINK2, during which all – then aged 11 to 17 years – wore the high-add lenses for two years followed by single-vision contact lenses for the third year, a method used to see if the benefit remained after discontinuing the bifocal treatment.

At the end of BLINK2, eye growth returned to age-expected rates and there were no signs of faster-than-normal eye growth. Participants who had been in the original BLINK high-add group continued to have shorter eyes and less myopia at the end of BLINK2, meaning those who started high-add bifocal lenses in BLINK2 did not catch up to those who received the treatment when they were younger.

“After the children discontinue using the contact lenses, their myopia progression increases, but just to normal standards you would expect if you hadn’t treated them. And that happens no matter what age they are when they stop wearing the bifocal lenses,” said Walline, also acting dean in Ohio State’s College of Optometry.

This research and other studies have led to advances in the treatment landscape for nearsighted children: Options include multifocal contact lenses, contact lenses that reshape the cornea during sleep called orthokeratology, and atropine eye drops.

“This is a burgeoning area,” Walline said. “The standard of care has switched from providing kids with single-vision glasses or contact lenses to things that slow down the progression of myopia, or the growth of the eye.”

Walline and his colleagues are now pursuing funding for a clinical trial to see if it’s possible to delay the onset of myopia in young children by administering atropine eye drops before nearsightedness is detectable.

“What we know is that the earlier you become myopic, the more myopia you’re expected to have as an adult. So if we can delay the onset, then we can make a big difference,” he said.

BLINK was funded by the National Institutes of Health’s National Eye Institute and supported by Bausch + Lomb, which provided contact lens solutions.

David Berntsen, Golden-Golden Professor and chair of clinical sciences at the University of Houston College of Optometry, was the first author of this study. Additional co-authors were Anita Tićak and Amber Gaume Giannoni of the University of Houston, and Danielle Orr, Loraine Sinnott, Donald Mutti and Lisa Jones-Jordan of Ohio State.

12/24/2024
12/20/2024

Diabetic retinopathy is treatable and preventable – but only if you catch it in time
USA TODAY
Daryl Austin, USA TODAY
December 17, 2024 at 5:02 AM
The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov public survey, only 2% of Americans say that, of the five senses, they would miss their ability to smell the most; 3% of respondents said their sense of touch matters most; and 5% said taste is most important. 7% said their ability to hear was the sense they appreciated more than any other. But by far the sense people cared most about was their ability to see. A whopping 70% of Americans say they would miss their sense of sight more than losing any of the other five senses.

While many eye conditions can affect or diminish vision, myopia is the most prevalent one with about 30% of the global population having it. Other degenerative eye conditions or diseases go beyond diminished vision, however, and can completely rob you of your ability to see. For example, age-related macular degeneration, retinitis pigmentosa and glaucoma can all lead to blindness.

Diabetic retinopathy is another condition that can cause complete loss of vision - and it's also one of the most frequently occurring. "Diabetic retinopathy is the most common cause of irreversible vision loss and blindness among people in the working age range in the USA and in many other countries," says Dr. Charles Wykoff, a medical and surgical retina specialist and an ophthalmologist practicing in Texas.

What is diabetic retinopathy?
Diabetic retinopathy (DR) is an eye-related complication that can occur in people who have diabetes. It affects blood vessels in the retina - the "light-sensitive layer of tissue in the back of the eye," explains Wykoff. DR can lead to peripheral or nighttime vision loss, visual disturbances such as oversensitivity to light and floaters, and, if left untreated, blindness.

DR has two stages, explains Dr. Sun Kim, an endocrinologist at Stanford University, who specializes in treating diabetes. The first and earlier stage is called nonproliferative retinopathy and occurs when the retina begins to swell, leading to mild vision loss. "Proliferative retinopathy is the advanced stage of DR that can cause severe and sometimes even complete loss of vision," Kim says.

The National Eye Institute estimates that nearly half of the 800 million people with diabetes worldwide will develop some degree of diabetic retinopathy. "The biggest risk factor for the development of DR in type 2 diabetes is duration of the disease - how long a person has had it," says Dr. Sara Weidmayer, a practicing physician at the LTC Charles S. Kettles VA Medical Center in Michigan.

What causes diabetic retinopathy?
DR is caused by high blood sugar levels that, over time, "affect the integrity of blood vessels, especially very small micro-vessels called capillaries," says Weidmayer. She explains that sustained glucose levels can cause the inside lining of these capillaries to become damaged, which then causes leakage that harms the retina. "The capillaries can also become plugged, leading to inadequate blood flow to many areas of the retina," she adds, which can further deteriorate vision.

While such leakage and plugged capillaries can persist for extended periods of time without causing noticeable vision loss, "if left untreated, it can eventually progress to permanent and irreversible vision loss," says Dr. Lloyd Paul Aiello, a professor of ophthalmology at Harvard Medical School.

In fact, the longer someone has diabetes and the less controlled their blood sugar is during that time, the more likely they are to develop more advanced degrees of DR. This is especially worrisome because "many patients don’t know they have prediabetes or diabetes for years before an official diagnosis due to lack of screening," cautions Weidmayer.

Indeed, about one in three American adults have prediabetes and more than eight in ten don't know they have it, notes the U.S. Centers for Disease Control and Prevention.

How is diabetic retinopathy treated?
Because of this, treating DR starts with monitoring your blood sugar levels and getting checked for prediabetes or type 2 diabetes. This is essential when it comes to preventing the worst outcomes of vision loss associated with DR, because, unlike type 1 diabetes where it is very rare to have severe diabetic retinopathy within the first 5 years after diagnosis, "in type 2 diabetes, retinopathy can exist at the time of diagnosis," Aiello explains. "For this reason, an initial retinal eye exam is recommended at the time of diagnosis for those with type 2 diabetes - and even if there is no retinopathy initially discovered, a patient will generally need to have their eyes examined at least annually."

Once the condition has been diagnosed, treatments are usually first focused on preventing further damage. "In early stages of DR, optimizing...risk factors such as elevated blood sugar levels, high blood pressure, and cholesterol levels is ultimately the best thing to do to prevent the development and/or worsening of diabetic retinopathy," says Weidmayer.

She says such measures include things like improving your diet, getting regular cardiovascular exercise, and quitting smoking. If needed, losing weight can be especially beneficial in improving blood sugar levels, Kim says - especially if your body mass index (BMI) is high.

If damage persists despite dietary and exercise improvements and you're found to have advanced DR, other interventions are recommended. "Medications may be injected into the eyes, laser procedures may be used, and often surgeries are needed to manage complications of DR," Weidmayer says.

"Most people with diabetic retinopathy do not go blind if they are screened for diabetic retinopathy as needed and receive appropriate treatment by a retina specialist," offers Wykoff. "This is why you shouldn't wait until you have blurry vision to see an eye doctor."

Our Rayban trunk sale has commenced. Visit us today until 7 for exclusive deals, raffles, and Rayban products not yet av...
12/12/2024

Our Rayban trunk sale has commenced. Visit us today until 7 for exclusive deals, raffles, and Rayban products not yet available in stores!

Don’t forget tomorrow to stop by the office for our Rayban trunk sale! There will be raffles for exclusive Raybans and m...
12/11/2024

Don’t forget tomorrow to stop by the office for our Rayban trunk sale! There will be raffles for exclusive Raybans and more!

Stop by for deals and holiday cheer!

12/08/2024

Free Home Try-On Program

12/08/2024

Free shipping and returns

03/01/2024

Comet 12P/Pons-Brooks, also known as the "devil comet," will be positioned close to the sun during the April 8 total solar eclipse. Some photographers also predict that the volcanic comet may be visible to the naked eye, especially if it blows its top before the big event.

02/02/2024

Here at Dr. Foti's office, we have a professional glasses expert to help you decide what shape and size lens look well on your face! Come in today for an eye exam and a free consultation from our specialist!


Address

200 Jefferson Road Suite 102
Wilmington, MA
01887

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 7pm
Wednesday 9am - 5pm
Thursday 9am - 7pm
Friday 9am - 5pm
Saturday 8am - 1pm

Telephone

+19786589512

Alerts

Be the first to know and let us send you an email when Dr Anthony J Foti posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Category